These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10350035)

  • 1. Interaction between olanzapine and haloperidol.
    Gomberg RF
    J Clin Psychopharmacol; 1999 Jun; 19(3):272-3. PubMed ID: 10350035
    [No Abstract]   [Full Text] [Related]  

  • 2. The economic consequences of a drug-drug interaction.
    Shad MU; Marsh C; Preskorn SH
    J Clin Psychopharmacol; 2001 Feb; 21(1):119-20. PubMed ID: 11199940
    [No Abstract]   [Full Text] [Related]  

  • 3. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol.
    Lee MD; Clifton PG
    Pharmacol Biochem Behav; 2002; 71(1-2):147-54. PubMed ID: 11812517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine and haloperidol: potential for neutropenia?
    Abdullah N; Voronovitch L; Taylor S; Lippmann S
    Psychosomatics; 2003; 44(1):83-4. PubMed ID: 12515844
    [No Abstract]   [Full Text] [Related]  

  • 6. Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol.
    Inada T; Beasley CM; Tanaka Y; Walker DJ
    Int Clin Psychopharmacol; 2003 Jan; 18(1):39-48. PubMed ID: 12490774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine.
    Hägg S; Mjörndal T; Lindqvist L
    J Clin Psychopharmacol; 2001 Feb; 21(1):113-5. PubMed ID: 11199936
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment: risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
    Lu ML; Shen WW
    Ann Pharmacother; 2002; 36(7-8):1292; author reply 1292-3. PubMed ID: 12086567
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine and tardive dyskinesia.
    Woods SW
    Br J Psychiatry; 1999 Oct; 175():391-2. PubMed ID: 10789313
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain.
    Timmerman W; Heijmen M; Westerink BH; Bruggeman R; den Boer JA
    Psychopharmacology (Berl); 1999 Jun; 144(3):286-94. PubMed ID: 10435397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
    Mujica R; Weiden P
    Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
    Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
    Ann Pharmacother; 2001 Dec; 35(12):1517-22. PubMed ID: 11793611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects.
    Kiang M; Daskalakis ZJ; Christensen BK; Remington G; Kapur S
    J Psychiatry Neurosci; 2003 Jul; 28(4):293-9. PubMed ID: 12921224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol-induced impotence improved by switching to olanzapine.
    Tsai SJ; Hong CJ
    Gen Hosp Psychiatry; 2000; 22(5):391-2. PubMed ID: 11203037
    [No Abstract]   [Full Text] [Related]  

  • 15. Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study.
    Robinson KA
    Clin Ther; 2000 Nov; 22(11):1375-6. PubMed ID: 11117662
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.
    Czekalla J; Beasley CM; Dellva MA; Berg PH; Grundy S
    J Clin Psychiatry; 2001 Mar; 62(3):191-8. PubMed ID: 11305706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine.
    Hale AS
    Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of novel antipsychotics on glucose and lipid levels.
    Wirshing DA; Boyd JA; Meng LR; Ballon JS; Marder SR; Wirshing WC
    J Clin Psychiatry; 2002 Oct; 63(10):856-65. PubMed ID: 12416594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of pharmacology to side effects.
    Casey DE
    J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of olanzapine.
    Beasley CM; Tollefson GD; Tran PV
    J Clin Psychiatry; 1997; 58 Suppl 10():13-7. PubMed ID: 9265911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.